SynthesisDermatology and therapy2026
Environmental and Neighborhood Determinants of Psoriasis: A Systematic Review of Pollution, Built Environment, and Socioeconomic Vulnerability on Psoriasis.
Synthesis in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and Ethnicities.Dermatology and therapy · 2026Article
- Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway.International journal of molecular sciences · 2026Article
- Superficial Fungal Infection Associations with Comorbid Diseases and Risk Factors: An Analysis of Global Burden of Disease 2023.Infectious disease reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psoriasis is a chronic, immune-mediated skin disease with well-studied genetic and immunologic drivers. Substantial unexplained variability remains, however, in disease onset, severity, and treatment response. There is evidence that implicates the role of environmental and social determinants in these observed differences in psoriasis. We conducted a systematic review to synthesize the current evidence examining the relationship between external exposures, including air and chemical pollution, the built environment, and neighborhood characteristics, and their impact on psoriasis incidence, severity, and exacerbation. Our search in PubMed and Embase (on August 8, 2025 and October 15, 2025, respectively) identified 26 eligible studies. These included nine cohort studies, four ecological studies, and 12 case-control studies. Papers that assessed exposures of ambient air pollutants, chemical pollutants, neighborhood, built environment, income, education, and insurance status were included. The risk of bias for each study was evaluated using the Critical Appraisal Skills Programme (CASP) criteria. Across diverse patient populations and study designs, higher exposure to air pollutants, such as particulate matter and nitrogen oxides, and chemical pollutants, including per- and polyfluoroalkyl substances (PFAS), was associated with increased disease incidence and severity. These were found to contribute to an independently increased risk of psoriasis, even among individuals with a genetic susceptibility to the disease. Climate change associated events, such as wildfires, were linked to increased healthcare utilization for psoriasis. Deleterious neighborhood-level exposures and poor social determinants were also associated with greater psoriasis incidence and exacerbation. Our analysis of existing limitations highlights the need for longitudinal and mechanistic studies to elucidate these relationships, and for the development of standardized definitions for environmental exposures. These findings support a framework for psoriasis that considers environmental and social determinants alongside genetic contributors. Addressing these risk factors requires broader public health initiatives that mitigate exposure and expand healthcare access to at-risk communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.